B6Dnk;B6Brd;B6N-Tyrc-Brd Sparctm1a(EUCOMM)Wtsi/WtsiCnbc

Status

Available to order

EMMA IDEM:05296
International strain nameB6Dnk;B6Brd;B6N-Tyrc-Brd Sparctm1a(EUCOMM)Wtsi/WtsiCnbc
Alternative nameEPD0060_1_A07
Strain typeTargeted Mutant Strains
Allele/Transgene symbolSparctm1a(EUCOMM)Wtsi
Gene/Transgene symbolSparc
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0060_1_A07. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
  • Identification of genes important for cutaneous function revealed by a large scale reverse genetic screen in the mouse.;DiTommaso Tia, Jones Lynelle K, Cottle Denny L, null null, Gerdin Anna-Karin, Vancollie Valerie E, Watt Fiona M, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, Sundberg John P, White Jacqueline K, Smyth Ian M, ;2014;PLoS genetics;10;e1004705; 25340873

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • decreased bone mineral density / IMPC
  • increased circulating calcium level / IMPC
  • abnormal coat/ hair morphology / IMPC
  • abnormal tibia morphology / IMPC
  • decreased body length / IMPC
  • decreased body weight / IMPC
  • abnormal lens morphology / IMPC
  • cataract / IMPC
  • abnormal coat/hair pigmentation / IMPC
  • abnormal eye morphology / IMPC
  • abnormal tooth morphology / IMPC
  • increased circulating alanine transaminase level / IMPC
  • increased lactate dehydrogenase level / IMPC
  • abnormal humerus morphology / IMPC
  • increased circulating creatine kinase level / IMPC
  • abnormal incisor color / IMPC
  • decreased bone mineral content / IMPC
IMPC phenotypes (gene matching)
  • abnormal coat/hair pigmentation / IMPC
  • increased lactate dehydrogenase level / IMPC
  • abnormal incisor color / IMPC
  • abnormal humerus morphology / IMPC
  • decreased body weight / IMPC
  • increased circulating creatine kinase level / IMPC
  • abnormal lens morphology / IMPC
  • decreased bone mineral density / IMPC
  • decreased body length / IMPC
  • cataract / IMPC
  • abnormal tibia morphology / IMPC
  • abnormal eye morphology / IMPC
  • abnormal tooth morphology / IMPC
  • decreased bone mineral content / IMPC
  • increased circulating alanine transaminase level / IMPC
  • increased circulating calcium level / IMPC
  • abnormal coat/ hair morphology / IMPC
MGI phenotypes (allele matching)
  • abnormal tibia morphology / MGI
  • decreased body weight / MGI
  • abnormal lens morphology / MGI
  • cataract / MGI
  • abnormal coat/hair pigmentation / MGI
  • abnormal eye morphology / MGI
  • abnormal tooth morphology / MGI
  • abnormal humerus morphology / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • abnormal incisor color / MGI
MGI phenotypes (gene matching)
  • decreased bone mineral density / MGI
  • abnormal trabecular bone morphology / MGI
  • abnormal tibia morphology / MGI
  • decreased body weight / MGI
  • abnormal lens morphology / MGI
  • cataract / MGI
  • retinal degeneration / MGI
  • hypoactivity / MGI
  • abnormal skeleton physiology / MGI
  • abnormal bone strength / MGI
  • eye inflammation / MGI
  • abnormal coat/hair pigmentation / MGI
  • abnormal eye morphology / MGI
  • abnormal tooth morphology / MGI
  • enhanced wound healing / MGI
  • abnormal lens fiber morphology / MGI
  • delayed wound healing / MGI
  • abnormal bone remodeling / MGI
  • retinal detachment / MGI
  • abnormal lens capsule morphology / MGI
  • abnormal lens epithelium morphology / MGI
  • increased tumor growth/size / MGI
  • abnormal retinal layer morphology / MGI
  • abnormal osteoclast morphology / MGI
  • decreased osteoclast cell number / MGI
  • abnormal osteoblast morphology / MGI
  • decreased osteoblast cell number / MGI
  • abnormal humerus morphology / MGI
  • hematopoietic system phenotype / MGI
  • abnormal skeleton morphology / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • vitreous body inflammation / MGI
  • ruptured lens capsule / MGI
  • abnormal incisor color / MGI
  • subcapsular cataracts / MGI
  • posterior subcapsular cataracts / MGI
  • cortical cataracts / MGI

Literature references

  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
  • Identification of genes important for cutaneous function revealed by a large scale reverse genetic screen in the mouse.;DiTommaso Tia, Jones Lynelle K, Cottle Denny L, null null, Gerdin Anna-Karin, Vancollie Valerie E, Watt Fiona M, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, Sundberg John P, White Jacqueline K, Smyth Ian M, ;2014;PLoS genetics;10;e1004705; 25340873

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).